NISHA SHAHA

The Global Orphan Drugs Market is estimated to be US$ 869.6 million by 2030 with a CAGR of 10.4% during the forecast period. Orphan drugs are the pharmaceutical mediators which are developed to treat rare medical conditions. Orphan drugs would not be able to earn profit because the orphan drugs are used to treat the rare diseases. It can only produce profit by the involvement of government assistant. Orphan drugs use to diagnoses and to prevent the diseases. Orphan drugs are not developed in industry, but it is generated for the public welfare. The report " Global Orphan Drugs Market, By Drug Type (Biological and Non- Biological), By Top Selling Drugs (Revlimid, Rituxan, Copaxone, Opdivo, Keytruda, Imbruvica, Avonex, Sensipar, Soliris, and Other Top Selling Drugs), By Disease Type (Oncology, Hematology, Neurology, Cardiovascular, and Other Disease Types), By Phase (Phase I, Phase II, Phase III, and Phase IV), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: In present scenario, there are several countries and organizations, which have defined “orphan” and “rare” diseases. The prevalence rate for each definition varies from organization to organization, and country to country. While, several developed markets have specific definition for such diseases and treatments, there are however, many countries in the emerging markets, which lack the proper definitions and guidelines, along with lack of proper guidance from the medical community and concerned authorities toward the orphan diseases. This is among the major challenges and restraints for growth of orphan medication, across a large part of the world. In August 2019, Janssen and AbbVie received the European Commission (EC) approval of imbruvica (ibrutinib) for expanded use in two indications. The regulator has approved expanding the scope of the drug to include its use in combination with obinutuzumab in adults with previously untreated chronic lymphocytic leukemia (CLL), and for the treatment of adults with Waldenström's macroglobulinemia (WM) in combination with rituximab. Analyst View: In present scenario, there are several countries and organizations, which have defined “orphan” and “rare” diseases. The prevalence rate for each definition varies from organization to organization, and country to country. While, several developed markets have specific definition for such diseases and treatments, there are however, many countries in the emerging markets, which lack the proper definitions and guidelines, along with lack of proper guidance from the medical community and concerned authorities toward the orphan diseases. This is among the major challenges and restraints for growth of orphan medication, across a large part of the world. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Orphan Drugs Market, By Drug Type (Biological and Non- Biological), By Top Selling Drugs (Revlimid, Rituxan, Copaxone, Opdivo, Keytruda, Imbruvica, Avonex, Sensipar, Soliris, and Other Top Selling Drugs), By Disease Type (Oncology, Hematology, Neurology, Cardiovascular, and Other Disease Types), By Phase (Phase I, Phase II, Phase III, and Phase IV), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Orphan-Drugs-Market-By-3793 Key Market Insights from the report: The Global Orphan Drugs Market is estimated to be US$ 869.6 million by 2030 with a CAGR of 10.4% during the forecast period. The global orphan drugs market is segmented based on drug type, disease, disease type, phase, and region. On the basis of drug type, the global orphan drugs market is segmented into biological and non- biological. On the basis of top selling drugs, the target market is segmented into revlimid, rituxan, copaxone, opdivo, keytruda, imbruvica, avonex, sensipar, soliris, and other top selling drugs. ased on disease type, the global market is classified into oncology, hematology, neurology, cardiovascular, and other disease types. On the basis of phase segment, the target market divided into phase I, phase II, phase III, and phase IV. Based on region the global orphan drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global market in North America region is seen to have a matured growth since this market correlates with the increasing growth rate of orphan disease. Competitive Landscape: The key players operating the global orphan drugs market involves AbbVie Inc., Celgene Corporation, Biogen, Teva Pharmaceutical Industries, F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Alexion Pharmaceuticals, Amgen, Merck & Co. Inc., Jazz Pharmaceuticals Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the drug types in order to gain competitive edge in the target market. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.com

The global drug discovery services market accounted for US$ 10.7 billion in 2020 and is estimated to be 19.1 billion by 2025 and is anticipated to register a CAGR of 12.1 %. The report. "Global Drug Discovery Services Market, By Process (Target Selection, Target Validation, Hit-to-lead Identification, Candidate Validation, and Others), By Type (Medicinal Chemistry, Biology Services, Drug Metabolism, Pharmaceutical Services, and Pharmacokinetics), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, and Others), By Drug Type (Small Molecules and Biologics), By Technology (High Throughput Screening, Biochips, Pharmacogenetics, Nanotechnology, and Spectroscopy), By End User (Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies, and Research Institute), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2025”. Key Highlights: In January 2020, Abbott Laboratories Inc. received expanded FDA clearance for its Deep Brain Stimulation system for Parkinson's disease. In October 2019, AstraZeneca PLC increased its sales outlook for the second quarter in a row as new drugs continued to prove popular, mainly in developing markets. New drugs sales raised 62% to US$ 2.7 bn in the quarter, including an 85% surge in evolving markets to US$ 539 mln In May 2019, BenevolentAI which is an AI company started AI collaboration with AstraZeneca to accelerate drug discovery Analyst View: Inclination of major pharmaceutical companies toward outsourcing to avoid hurdles Major pharmaceutical companies involved in drug discovery and services are shifting their focus on attaining a significant position in developing countries such as India, China, Brazil, and Mexico in order to enlarge their business strategies and explore new markets. Developing nations in Asia Pacific are launching early-stage research programs, in order to meet the specific medical requirements of patients in the region. This is likely to drive the global drug discovery services market growth. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Drug Discovery Services Market”, By Process (Target Selection, Target Validation, Hit-to-lead Identification, Candidate Validation, and Others), By Type (Medicinal Chemistry, Biology Services, Drug Metabolism, Pharmaceutical Services, and Pharmacokinetics), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, and Others), By Drug Type (Small Molecules and Biologics), By Technology (High Throughput Screening, Biochips, Pharmacogenetics, Nanotechnology, and Spectroscopy), By End User (Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies, and Research Institute), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030 Key Market Insights from the report: The global drug discovery services market accounted for US$ 10.7 billion in 2020 and is estimated to be 19.1 billion by 2025 and is anticipated to register a CAGR of 12.1 %. The market report has been segmented on the basis of process, type, therapeutic area, drug type, technology, end-user, and region. By process, the target market is segmented into target selection, target validation, hit-to-lead identification, candidate validation, and others. By type, the medicinal chemistry services segment is accounted for highest share of the drug discovery services market in 2020, owing to factors such as the extensive applications of preclinical drug discovery in various phases of medicinal chemistry to deliver robust candidates. By therapeutic area, the oncology segment is projected to register largest market share in 2020, primarily due to growing number of patients who have cancer and the subsequent growth in the demand for cancer therapies. By drug type, small molecule drugs are projected to register for the highest market share in 2020, as small-molecule drugs are well-defined, simple, and easy to characterize. By technology, the target market is segmented into high throughput screening, biochips, pharmacogenetics, nanotechnology, and spectroscopy. By end-user, the target market is segmented into hospital & clinics, pharmaceutical companies, biotechnology companies, and research institute. By region, North America and Europe are projected to maintain their dominance over the forecast period owing to advanced health care infrastructure. To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Drug-Discovery-Services-Market-4223 Competitive Landscape: The prominent player operating in the global drug discovery services market includes Abbott Laboratories Inc., Agilent Technologies Ubiquigent, Advinus Therapeutics, Albany Molecular Research Inc., AstraZeneca PLC, Aurigene, Charles River Laboratories International, Bayer AG, ChemBridge Corporation, and Covance. The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces Analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights Email- sales@prophecymarketinsights.com

The Global Stem Cell Assay Market accounted for US$ 1103.85 million in 2020 and is estimated to be US$ 6619.42 million by 2030 and is anticipated to register a CAGR of 19.8%. Stem cells are special human cells that are able to develop into many different cell types. This can range from muscle cells to brain cells. In some cases, they can also fix damaged tissues. Researchers believe that stem cell-based therapies may one day be used to treat serious illnesses such as paralysis and Alzheimer disease. The only stem cells now used to treat disease are hematopoietic stem cells. These are the blood cell-forming adult stem cells found in bone marrow. Every type of blood cell in the bone marrow starts as a stem cell. Stem cells are immature cells that are able to make other blood cells that mature and function as needed. The report " Global Stem Cell Assay Market, By Type (Viability/Cytotoxicity, Isolation/Purification, Cell Identification, Proliferation, Cell Differentiation, Cell Function, and Cell Apoptosis Assays), By Kit (Adult Stem Cells Kit and Human Embryonic Stem Cells Kits), By Detection (Instruments and Detection Kits), By Instrument (Flow Cytometer, Micro Electrode Arrays, Cell Imaging Systems, and Automated Cell Counter), By Application (Regenerative Medicine And Therapy Development, Drug Discovery & Development, and Clinical Research), By End User (Government Research Institutes, Private Research, and Industry Research), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: On 24th July 2021, Edward Holland, MD, announced the launch of the Holland Foundation for Site Restoration with a goal of establishing Centers of Excellence (COEs) throughout the country that would specialize in site restoration procedures. In 2021, Johnson & Johnson Vision announced the global launch of the Veritas Vision System, a next-generation phacoemulsification system, according to a company press release. Analyst View: The major factors boosting the growth of the global stem cell assay market include rising expenditure in research-related activities, advancement in technologies, and increased frequency of chronic diseases. However, the growth of the market can be hindered owing to the huge cost of stem cell-based therapies and strict regulatory recommendation. Rise in approvals of clinical trials for stem cell based therapy, high prevalence of chronic diseases, increase in research related activities in stem cells, and technological advancements in the area of stem cell assays method supplements the growth of the stem cell assay market. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Stem Cell Assay Market, By Type (Viability/Cytotoxicity, Isolation/Purification, Cell Identification, Proliferation, Cell Differentiation, Cell Function, and Cell Apoptosis Assays), By Kit (Adult Stem Cells Kit and Human Embryonic Stem Cells Kits), By Detection (Instruments and Detection Kits), By Instrument (Flow Cytometer, Micro Electrode Arrays, Cell Imaging Systems, and Automated Cell Counter), By Application (Regenerative Medicine And Therapy Development, Drug Discovery & Development, and Clinical Research), By End User (Government Research Institutes, Private Research, and Industry Research), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Stem-Cell-Assay-Market-3910 Key Market Insights from the report: The Global Stem Cell Assay Market accounted for US$ 1103.85 million in 2020 and is estimated to be US$ 6619.42 million by 2030 and is anticipated to register a CAGR of 19.8%. The Global Stem Cell Assay Market is segmented based on the type, kit, detection, instrument, application, end-user and region. By Type, the Global Stem Cell Assay Market is segmented into Viability/Cytotoxicity, Isolation/Purification, Cell Identification, Proliferation, Cell Differentiation, Cell Function, and Cell Apoptosis Assays. By Kit, the Global Stem Cell Assay Market is segmented into Adult Stem Cells Kit and Human Embryonic Stem Cells Kits. By Detection, the Global Stem Cell Assay Market is segmented into Instruments and Detection Kits. By Instrument, Global Stem Cell Assay Market is segmented into Flow Cytometer, Micro Electrode Arrays, Cell Imaging Systems, and Automated Cell Counter. By Application, the Global Stem Cell Assay Market is segmented into Regenerative Medicine and Therapy Development, Drug Discovery & Development, and Clinical Research. By End-User, the Global Stem Cell Assay Market is segmented into Government Research Institutes, Private Research, and Industry Research. By region, the Global Stem Cell Assay Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the worldwide leader in the stem cell assay market in terms of revenue, due to the developed healthcare system and health awareness among people. Competitive Landscape: The key players operating the global stem cell assay market involves GE Healthcare, Promega Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Cell Biolabs, Inc., Hemogenix, STEMCELL Technologies Inc., Bio-Rad Laboratories Inc., R&D Systems Inc., and Cellular Dynamics International Inc. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.co

The global hormone replacement therapy market accounted for US$ 7.16 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 7.50%. Hormone replacement therapy (HRT), also known as menopausal hormone therapy or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause.These symptoms can include hot flashes, vaginal atrophy, accelerated skin aging, vaginal dryness, decreased muscle mass, sexual dysfunction, and bone loss. They are in large part related to the diminished levels of sex hormones that occur during menopause. The main hormonal medications used in HRT for menopausal symptoms are estrogens and progestogens, among which progesterone is the major naturally-occurring female sex hormone and also a manufactured medication used in menopausal hormone therapy. Though both can have symptomatic benefits, progestogen is specifically added to estrogen regimens when the uterus is still present. Unopposed estrogen therapy promotes endometrial thickening and can increase the risk of cancer, while progestogen reduces this risk. Androgens like testosterone are sometimes used as well. HRT is available through a variety of different routes. The report " Global Hormone Replacement Therapy Market, By Therapy Type (Human Growth Hormone (HGH) Replacement Therapy, Testosterone Replacement Therapy, Thyroid Replacement Therapy, Estrogen Replacement Therapy), By Application (Growth Hormone Deficiency, Menopause, Hypothyroidism, Male Hypogonadism, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa ) - Trends, Analysis and Forecast till 2030” Key Highlights: In December 2020, US FDA approved the Myovant Sciences' Orgovyx (relugolix), which is an orally administered treatment that works by blocking the pituitary from making hormones called LH and FSH, thus resulting in the reduction within the amount of testosterone produced by the testicles. Thus, aiding within the treatment of adult patients with advanced prostatic adenocarcinoma. In August 2020, Bayer AG announced the acquisition of KanDy Therapeutics, Inc, which aids within the expansion of Bayer's women's drug pipeline by adding KanDy's menopause drug thereto portfolio. Analyst View: High prevalence of hormone related disorder is expected to drastically increase the demand for hormone replacement therapy market in near future. As per estimated of American Thyroid Association (ATA), More than 12 percent of the U.S. population will develop a thyroid condition during their lifetime and around 20 million Americans have some form of thyroid disease. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on ‘Global Hormone Replacement Therapy Market, By Therapy Type (Human Growth Hormone (HGH) Replacement Therapy, Testosterone Replacement Therapy, Thyroid Replacement Therapy, Estrogen Replacement Therapy), By Application (Growth Hormone Deficiency, Menopause, Hypothyroidism, Male Hypogonadism, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa ) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Hormone-Replacement-Therapy-Market-123# Key Market Insights from the report: The global hormone replacement therapy market accounted for US$ 7.16 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 7.50%. The global hormone replacement therapy market has been segmented on the basis of therapy type, application, route of administration, distribution channel and region. By Therapy Type, the market is segmented into human growth hormone (HGH) replacement therapy, testosterone replacement therapy, thyroid replacement therapy, and estrogen replacement therapy. By Application, the market is segmented into growth hormone deficiency, menopause, hypothyroidism, male hypogonadism, and others. By Route of Administration, the Global Hormone Replacement Therapy Market is segmented into oral, parenteral, and others. By Distribution Channel, the Global Hormone Replacement Therapy Market is segmented into hospital, retail pharmacies, and online pharmacies. By Region, the Global Hormone Replacement Therapy Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region is expected to be the largest hormone replacement therapy market. Competitive Landscape: The Key players operating in the global Hormone replacement therapy market includes, Merck KgaA, Abbott Laboratories, Eli Lilly and Company, Novartis International AG, Pfizer Inc., Bayer AG, QuatRx Pharmaceuticals, Mylan N.V., Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Novo Nordisk A/S. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning. Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period. Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.com

The report "Global Protein Engineering Market, By Product Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Other Product Types), By Technology (Irrational Protein Design, and Rational Protein Design), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030. Key Highlights: In June 2019, Thermo Fisher Scientific Launches powerful Invitrogen iBright 1500 imaging system for western blot and gel imaging. In July 2019, Amgen and the University of Washington's Institute for Protein Design (IPD), which is revolutionizing its field of science by creating custom-designed proteins from scratch to improve human health, today announced a broad collaboration that will cover multiple projects with a goal of testing new technologies and creating protein-building approaches that can be broadly applied to the search for new medicines. Analyst View: The propelling factors for the growth of the global protein engineering market include the increasing prevalence of protein deficient diseases, increase in adoption of protein drugs over non-protein drugs. In addition, increased demand for alternatives to chemical processes, and rising government funding for protein engineering will further boost the growth of target market. Factors such as the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies are expected to drive the growth of global protein engineering market. There is a rising number of government initiatives, such as funding R&D for protein engineering and awareness programs, which have influenced the healthcare industry. The government is thus proactively investing in many of the research studies. For instance, Protein Technologies Ltd (PTL) has received funding from the UK government’s Technology Strategy Board (now Innovate UK) for its innovative research in protein engineering. Hence the increasing number of government initiatives for the efficient protein engineering research helps in driving the overall growth of the market. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Protein Engineering Market”, By Product Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Other Product Types), By Technology (Irrational Protein Design, and Rational Protein Design), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030 Key Market Insights from the report: The global Protein Engineering market accounted for US$ 2.9 billion by 2024 and is projected to register a moderate CAGR of 15.80% over the forecast period. The market report has been segmented on the basis of product type, technology, end user, and region. By product type, monoclonal antibody accounted for a dominant share of the protein type segment and are anticipated to grow at a lucrative rate during the forecast period. Growing R&D expenditure in development of therapeutically advanced mAbs is presumed to be one of the significant factors responsible for increased adoption of these tools. By technology, rational design dominated the technology segment with a share of over 39.0%. The dominant share can be attributed to extensive usage of this technology in antibody and enzyme engineering. By end user, Pharmaceutical & biotechnology companies held a dominant share in the end-use segment in 2016. The substantial share can be attributed to the increasing adoption of in silico models to develop new protein-based drugs in the following applications: cancer, diabetes, and central nervous system diseases. By region, North America captured a dominant share of the market. Consistent number of collaborations encouraged by key market players for increasing their R&D capabilities are presumed to be responsible for the greater share captured by this region. To know the upcoming trends and insights prevalent in this market, click the link below: Links: https://prophecymarketinsights.com/market_insight/Global-Protein-Engineering-Market-By-4118 Competitive Landscape: The prominent player operating in the global Protein Engineering market includes Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Amgen Inc., Bruker Corporation, General Electric, PerkinElmer, Inc., Genscripts USA, Inc., and Sigma-Aldrich Corporation. The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with focus on R&D strategies, corporate structure, localization strategies, production capabilities, and sales performance of various companies Detailed analysis of this XYZ market revenue in previous & next coming years Examining various outlooks of the XYZ market with the help of Porter’s five forces analysis. Study on the product type that is anticipated to dominate the XYZ market. Study on the regions that are expected to register the fastest growth over the forecast period. Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights Email- sales@prophecymarketinsights.com

Global Ammonia Market accounted for US$ 65.23 billion in 2020 and is estimated to be US$ 117.43 billion by 2030 and is anticipated to register a CAGR of 6.10%. Ammonia is a colourless, smelly gas that contains 82.25 percent nitrogen and 17.75 percent hydrogen and is used for direct soil application and water irrigation. Chemical fertilisers, synthetic fibres, resins, and other goods all use ammonia as a raw material. Ammonia is used in the production of nitrogen solutions, ammonium sulphate, ammonium phosphates, urea, ammoniated super-phosphate fertilisers, and liquid fertilisers, as well as for the oxidation of ammonia to nitric acid, which is used in the production of nitric phosphates and ammonium, calcium, sodium, and potassium nitrates. Ammonia's propensity to mix immediately with acids to produce salts is one of its most distinguishing characteristics. Ammonium salts are chemicals such as ammonium nitrate (often used in fertilisers and explosives), ammonium phosphate, and ammonium carbonate that are formed as a result of this process. Around 80% of ammonia produced globally is utilised to make mineral fertilisers, with the remainder being used for technological purposes. The report " Global Ammonia Market, By Product Form (Liquid, Gas and Powder), By Application (Fertilizers, Refrigerants, Pharmaceuticals, Textile and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029’’ Key Highlights: In March 2020, OCI NV will have established a maritime value chain and commercialised ammonia and methanol as future shipping fuels, thanks to a partnership with MAN Energy Solutions, Hartmann Group, and Eastern Pacific Shipping. Industries Qatar, one of the region's industrial behemoths, said in August 2020 that its Board of Directors had authorised the planned acquisition of Qatar Petroleum's 25% ownership in Qatar Fertiliser Company (QAFCO) at a meeting on August 23, 2020. The purchase of QP's QAFCO interest is consistent with IQ's objective of expanding its downstream presence and creating value. Analyst View: The ammonia market has grown significantly over the years, and this trend is projected to continue in the next years due to increased demand for various agricultural fertilisers. Increased population is one of the key factors influencing demand, which has boosted demand for agriculture and related agrochemical products. Increased demand for food crops is due from Asia Pacific's fast growing population. Large-scale adoption of fertilisers and plant nutrition products is being driven by the need to boost yield per unit of cultivated area in order to satisfy rising production demands. The demand for ammonia, a vital raw ingredient used in the production of agrochemicals such as fertilisers, is increasing. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Ammonia Market, By Product Form (Liquid, Gas and Powder), By Application (Fertilizers, Refrigerants, Pharmaceuticals, Textile and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Ammonia-Market-By-Product-1356 Key Market Insights from the report: Global Ammonia Market accounted for US$ 65.23 billion in 2020 and is estimated to be US$ 117.43 billion by 2030 and is anticipated to register a CAGR of 6.10%. The global ammonia market report segments the market on the basis of product form, application, and region. Based on Product Form, Global Ammonia Market is segmented into Liquid, Gas and Powder. Based on Application, Global Ammonia Market is segmented into Fertilizers, Refrigerants, Pharmaceuticals, Textile and Others. By Region, the Global Ammonia Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Competitive Landscape & their strategies of Global Ammonia Market: The key players operating in the ammonia market are Bloomberg LP, BASF SE, Agrium, Inc., Koch, Nitrogen Company, CF Industries, Inc., Potash Corporation of Saskatchewan, Inc., Rashtriya, Chemicals & Fertilisers Ltd., Shandong Lianmeng Chem Group, Koch Industries, Inc. and EuroChem Group AG The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.com Website- www.prophecymarketinsights.com

The Global Zero Liquid Discharge Market accounted for US$ 6.31 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 8.9%. Zero fluid release (ZLD) alludes to atreatment cycle in which the plant releases no fluid emanating into surface waters, essentially totally taking out the natural contamination related with treatment. Aside from this advantage, a ZLD cycle additionally utilizes wastewater treatment, reusing, and reuse, consequently adding to water preservation through utilizing fresh water. Difficulties of ZLD in an assortment of cycle plants, for example, mass medication producers, material industrial facilities, and substance and manure plants. Making zero release arrangements can be cultivated by concentrating the profluent utilizing different strategies, including film based and various impact vanishing based frameworks, and recuperation and reusing of water. Different guidelines have been figured and carried out by concerned ecological organizations and government specialists focused on preservation of water and avoidance of water contamination. The report " Global Zero Liquid Discharge Market, By Type (Conventional ZLD System, and Hybrid ZLD System), By Application (Energy & Power, Food & Beverages, Chemicals & Petrochemicals, Textile, and Pharmaceuticals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029’’ Key Highlights: In November 2018, Veolia Water Technologies set up another plant, AQUAVISTA, which is an all-encompassing advanced arrangement made out of a set-up of canny programming answers for continuous improvement of cycle execution. It gives an auto-pilot instrument to the streamlining of the whole wastewater framework, including sewer organizations and treatment plants. This development assisted Veolia Water Technologies with growing its geological presence and item portfolio in the negligible fluid release market. Analyst View: Expanding natural guidelines coordinated toward wastewater released from such force plants are relied upon to drive the development of the worldwide zero fluid release market during the estimate time frame. The worldwide zero fluid release market is assessed to be exceptionally merged and contest bases on upgraded market situating in the water treatment innovation space. Driving business sector players represent around half of the portion of the overall industry and to acquire an upper hand, they keep on profiting by essential acquisitions. For example, in September 2017, Suez procured GE Water and Process Technologies, to cover the whole worth chain of the water asset the executives and expand admittance to modern customers. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Zero Liquid Discharge Market, By Type (Conventional ZLD System, and Hybrid ZLD System), By Application (Energy & Power, Food & Beverages, Chemicals & Petrochemicals, Textile, and Pharmaceuticals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Zero-Liquid-Discharge-Market-2094 Key Market Insights from the report: The Global Zero Liquid Discharge Market accounted for US$ 6.31 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 8.9%. The global zero liquid discharge market report segments the market on the basis of type, application, and region. Based on Type, Global Zero Liquid Discharge Market is segmented into Conventional ZLD System, and Hybrid ZLD System. Based on Application, Global Zero Liquid Discharge Market is segmented into Energy & Power, Food & Beverages, Chemicals & Petrochemicals, Textile, and Pharmaceuticals. By Region, the Global Zero Liquid Discharge Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Competitive Landscape & their strategies of Global Zero Liquid Discharge Market: Key players operating in the zero liquid discarge market include Aquatech International, Veolia, GEA Group Aktiengesellschaft, SUEZ, ENCON Evaporators, AQUARION, 3V Green Eagle, Thermax Global, Oasys Water and Praj Industries. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.com Website- www.prophecymarketinsights.com

Global Biopsy Devices Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 3.69 billion by 2030 and is anticipated to register a CAGR of 6.1%. The biopsy is used to perform surgical removal of tissue from an organ to determine the extent of disease, generally inflammatory and cancerous conditions. They perform by radiologists, interventional cardiologists, and surgeons. Each biopsy device is used according to the types of the organ under consideration. Conventional biopsy devices are complemented with advanced imaging technologies, like a stereotactic-guided biopsy, MRI-guided biopsy, CT scans, ultrasound-guided biopsy, and others to perform a biopsy with minimal invasiveness. Equipment like forceps, aspiration needles and localization wires are commonly used in biopsy devices. These devices are used in the needle-based, core, and vacuum-assisted biopsies of body parts, including the lungs, breast, liver, and kidney. They have various applications in healthcare such as diagnostic centers, medical clinics, and hospitals. The report " Global Biopsy Devices Market, By Device Type (Breast biopsy devices, Gastrointestinal (GI) biopsy devices, Soft tissue biopsy devices, Bronchial biopsy devices, Gynecological biopsy devices, Robotic biopsy devices, and Other devices), By Imaging Technology (CT scan, Stereotactic-guided biopsy, Ultrasound-guided biopsy, MRI-guided biopsy, and Others), By Application (Breast biopsy, Gastrointestinal (GI) biopsy, Prostate, Liver, Lung, Kidney, Gynecological, and Others), By End-User (Diagnostics and Hospitals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: On 16 March 2021, IZI Medical Products, LLC leading manufacturer of medical devices for radiology and oncology procedures, launched fully automated Quick-Core Auto Biopsy System for soft tissue biopsy. The Quick-Core Auto is a fully automatic biopsy device and lightweight, that builds upon the legacy of IZI's Quick-Core semi-automatic biopsy system, and offers the same reliability, precision, and quality. Hologic announced enhancement in Brevera with CorLumina Imaging Technology in August 2020. Which integrates vacuum-assisted tissue acquisition, real-time imaging verification, and advanced post-biopsy handling, the innovation will fuel the customer base of the firm. On 24 February 2021, Twist Bioscience Launched Industry-Leading NGS Methylation Detection System for Liquid Biopsy Cancer Analysis and Epigenetic Studies. Company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and a robust, end-to-end sample preparation and target enrichment solution for identifying methylated regions in the human genome. Analyst View: The increasing instance of chronic medical ailments, mainly breast cancer, is the key factor driving the growth of the market. In addition, increasing consumer awareness regarding the availability of screening procedures and diagnostics for chronic disease is rising the demand for integral technologies such as stereotactic-guided biopsies. Growing preference for minimally invasive (MI) biopsy procedures among patients across the globe is increasing the growth of the biopsy device market, For instance, the MI breast biopsy technique (MIBT) eliminates the need for surgery of cancer diagnosis while preserving the healthy tissue from damage caused by radiation. Furthermore, technological advancements include the development of vacuum-assisted guns and smart biopsy system that aid in distinguishing healthy cells from tumorous ones which also supports the growth of the market. The rapidly growing geriatric population, extensive research, and development activities increasing healthcare expenditure are driving the market in the coming years. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “ Global Biopsy Devices Market, By Device Type (Breast biopsy devices, Gastrointestinal (GI) biopsy devices, Soft tissue biopsy devices, Bronchial biopsy devices, Gynecological biopsy devices, Robotic biopsy devices, and Other devices), By Imaging Technology (CT scan, Stereotactic-guided biopsy, Ultrasound-guided biopsy, MRI-guided biopsy, and Others), By Application (Breast biopsy, Gastrointestinal (GI) biopsy, Prostate, Liver, Lung, Kidney, Gynecological, and Others), By End-User (Diagnostics and Hospitals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Biopsy-Devices-Market-By-2809 Key Market Insights from the report: Global Biopsy Devices Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 3.69 billion by 2030 and is anticipated to register a CAGR of 6.1%. The Global Biopsy Devices Market is segmented by Device Type, Application, Imaging Technology, End-user, and Region. By Device type, Global Biopsy Devices Market is segmented into Breast biopsy devices, Gastrointestinal (GI) biopsy devices, Soft tissue biopsy devices, Bronchial biopsy devices, Gynecological biopsy devices, Robotic biopsy devices, and other devices. By Application, Global Biopsy Devices Market is segmented into Breast biopsy, Gastrointestinal (GI) biopsy, Prostate, Liver, Lung, Kidney, Gynecological, and Others. By imaging technology, Global Biopsy Devices Market is segmented into CT scan, Stereotactic-guided biopsy, Ultrasound-guided biopsy, MRI-guided biopsy, and others. By End user, Global Biopsy Devices Market is segmented into Diagnostics and Hospitals. By Region, Global Biopsy Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa Competitive Landscape: The key operators of the Global Biopsy Devices Market are Bard Inc., Leica Biosystems, Dickinson and Company, Ethicon EndoSurgery Inc., Fujifilm Medical Systems, Veran Medical Technologies, Boston Scientific Corporation, MDxHealth, Medtronic, Argon Medical Devices Inc. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.com

The Global Refurbished Medical Devices Market accounted for US$ 10.5 billion in 2020 and is estimated to be US$ 31.2 billion by 2030 and is anticipated to register a CAGR of 11.8%.Needles are sterile devices that used to inject medication solutions into the body. It is also used to isolate numerous types of body fluids, include blood from veins and tissues from swollen joints. Needles are made up of plastic, glass, stainless steel and PEEK materials with a pointed tip. Moreover, it is segmented on the basis of mode of administration and has broad therapeutic application. Constant product launches and rising acquisitions and mergers between manufacturers of needles and government associations are a major trend in the Global Refurbished Medical Devices Market. The report “Global Refurbished Medical Devices Market, By Product (Medical Imaging Equipment, Operating Room & Surgical Equipment, Patient Monitors, Cardiovascular & Cardiology Equipment, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: In 2020, Siemens Healthineers (Germany) and Hamilton Health Sciences (Canada) have signed a 15 years contract which will be extended by another 10 years to supply comprehensive services for the newest imaging equipment at Hamilton Health Sciences hospitals in Canada. The deal size was approximately USD 192 million. In 2019, US Med-Equip (US) acquired Medical Support Products (US) to extend the potential, national expansion, and supply greater product and repair solutions across the US. In 2018, Koninklijke Philips (Netherlands) acquired AGITO Medical (Denmark), strengthening its refurbished medical equipment portfolio of products, parts, and services. Analyst View: The rise in number of new hospitals that are electing for alternate options to cut down on the investments of money. Using refurbished devices can be affordable and available for also below economy class people. This is the major propelling factor for the growth of the target market. Rise in advancement and increasing the emerging technologies, the trend of using affordable buying devices that is refurbished medical devices has been an increasing which is the boosting factor for the growth of the target market. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Refurbished Medical Devices Market, By Product (Medical Imaging Equipment, Operating Room & Surgical Equipment, Patient Monitors, Cardiovascular & Cardiology Equipment, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Refurbished-Medical-Devices-Market-4217 Key Market Insights from the report: The Global Refurbished Medical Devices Market accounted for US$ 10.5 billion in 2020 and is estimated to be US$ 31.2 billion by 2030 and is anticipated to register a CAGR of 11.8%. The Global Refurbished Medical Devices Market is fragmented on the basis of product, and region. By Product, the Global Refurbished Medical Devices Market is segmented into Medical Imaging Equipment, Operating Room & Surgical Equipment, Patient Monitors, Cardiovascular & Cardiology Equipment, and Others. By region, the Global Refurbished Medical Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region is expected to dominate the target market over the forecast period due to increasing incident of the various chronic disease. Competitive Landscape: The key players operating the global refurbished medical devices market includes Agito medical A/S, Avante Health Solutions, Block Imaging International, Inc., Everx Pvt. Ltd., GE Healthcare, Integrity Medical systems Inc., Koninklijke Philips N.V., Radio Oncology Systems Inc., Siemens Healthcare Systems, and Soma Technology. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.com

The Global Nasal Drug Delivery Systems Market accounted for US$ 51.20 billion in 2020 and is estimated to be US$ 92.47 billion by 2030 and is anticipated to register a CAGR of 6.1%. Nasal drug delivery is most preferred route of administration in treatment of allergic and non-allergic rhinitis, nasal congestion, and common cold. Intranasal route can be cross the blood brain barrier and deliver the drug molecules to the central nervous system. The drugs are also been administered via nasal route for therapeutic and recreational purpose, with the help of nasal drug delivery systems. Nasal drug delivery is advisable for drugs undergoing extensive first pass effect. Further, intranasal route is also exploited for bypassing the blood brain barrier and delivery the drugs molecules to the central nervous system. The nasal drug delivery systems are different for different drug, depending on their formation, as liquid nasal preparations are administered through inhalers, droppers, spray pumps, atomizers, or nebulizers. The report “Global Nasal Drug Delivery Systems Market, By Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, and Others), By Container Type (Non-pressurized Containers, and Pressurized Containers), By System Type (Multi-dose, Bi-dose, and Unit dose), By Therapeutic Application (Allergic and Non-allergic Rhinitis, Nasal Congestion, Vaccination, and Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: In 2019, Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. This marks the first FDA approval and U.S. launch of a prescription drug using Aptar Pharma’s patented Bidose nasal spray delivery system. Analyst View: Increasing prevalence of diseases is major factor driving growth of the Global Nasal Drug Delivery Systems Market. In addition, advantages associated nasal drug delivery systems such as drug degradation that is observed in gastrointestinal tract is absent and rapid drug absorption takes place are major factors in turn creating demand for the nasal drug delivery systems which is supporting growth of the target market currently. Furthermore, rising patient preference for nasal drug delivery as a result of easy administration and better efficacy as well as increasing adoption of self-administration practices are some among the major factors expected to propel growth of the nasal drug delivery systems market. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Nasal Drug Delivery Systems Market, By Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, and Others), By Container Type (Non-pressurized Containers, and Pressurized Containers), By System Type (Multi-dose, Bi-dose, and Unit dose), By Therapeutic Application (Allergic and Non-allergic Rhinitis, Nasal Congestion, Vaccination, and Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Nasal-Drug-Delivery-Systems-252 Key Market Insights from the report: The Global Nasal Drug Delivery Systems Market accounted for US$ 51.20 billion in 2020 and is estimated to be US$ 92.47 billion by 2030 and is anticipated to register a CAGR of 6.1%. Global nasal drug delivery systems market is segmented on the basis of dosage form, container type, system type, therapeutic application, distribution channel, and region. By Dosage Form, the Global Nasal Drug Delivery Systems Market is segmented into nasal spray, nasal drops, nasal gels, nasal powders, and others. By Container Type, the Global Nasal Drug Delivery Systems Market is segmented into non-pressurized and pressurized container. By System Type, the Global Nasal Drug Delivery Systems Market is segmented into multi-dose, bi-dose, and unit dose. By Therapeutic Application, the Global Nasal Drug Delivery Systems Market is segmented into allergic and non-allergic rhinitis, nasal congestion, vaccination, and others. By Distribution Channel, the Global Nasal Drug Delivery Systems Market is segmented into hospitals pharmacies, retail pharmacies, and online pharmacies. By region, the Global Nasal Drug Delivery Systems Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is expected to account for major revenue share as compared to that of other regions. Competitive Landscape: Key players operating in the global nasal drug delivery system market Merck & Co., GlaxoSmithKline plc., AstraZeneca plc., Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.co

The Global Hereditary Angioedema Market accounted for US$ 2.70 billion in 2020 and is estimated to be US$ 6.36 billion by 2030 and is anticipated to register a CAGR of 8.9%. Herbal medicine (also herbalism) is that the study of pharmacognosy and therefore the use of medicinal plants, which are a basis of traditional medicine. There is limited scientific evidence for the security and efficacy of plants utilized in 21st century herbalism, which generally doesn't provide standards for purity or dosage. The scope of herbal medicine commonly includes fungal and bee products, also as minerals, shells and certain animal parts. Herbal medicine is additionally called phytomedicine or phytotherapy. The report “Global Hereditary Angioedema Market, By Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), By Route of Administration (Subcutaneous, Intravenous, and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: In 2021, Sandoz, a global leader in generic and biosimilar medicines, announced the US launch of generic Icatibant injection pre-filled syringe to treat acute attacks of rare disease hereditary angioedema (HAE) in adults 18 years and older. It is available immediately for US patients. Analyst View: Growing research and development activities by key players in this market, coupled with increased support by various government and healthcare regulatory bodies operating in treatment of hereditary angioedema are major factors driving growth of the market. For instance, in 2017, the U.S. Food and Drug Administration (FDA) approved CSL Behring’s Haegarda (C1-esterase inhibitor), which is indicated for routine prophylaxis to prevent hereditary angioedema attacks in adolescent and adult patients. In September 2018, Health Canadahas authorizedShire plc’s TAKHZYRO (lanadelumab injection) for prevention of hereditary angioedema (HAE) attacks in adolescents and adults 12 years of age and older. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Hereditary Angioedema Market, By Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), By Route of Administration (Subcutaneous, Intravenous, and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Hereditary-Angioedema-Market-By-42 Key Market Insights from the report: The Global Hereditary Angioedema Market accounted for US$ 2.70 billion in 2020 and is estimated to be US$ 6.36 billion by 2030 and is anticipated to register a CAGR of 8.9%. The global hereditary angioedema market has been segmented on the basis of drug class, route of administration, distribution channel, and region. By Drug Class, the Global Hereditary Angioedema Market is segmented into C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others. By Route of Administration, the Global Hereditary Angioedema Market is segmented into Subcutaneous, Intravenous, and Oral. By Distribution Channel, the Global Hereditary Angioedema Market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. By region, the Global Hereditary Angioedema Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Competitive Landscape: Key players operating in the global hereditary angioedema market includes CSL Behring, Shire Plc., Pharming Healthcare, Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Adverum Biotechnologies, and Attune Pharmaceuticals, Inc. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.com

Changes in consumers preferences to shift from 3D-based medical devices to 4D-based and focus of key players to develop 4D printing applications for targeted drug delivery is projected to boost the market growth The global 4D printing in healthcare market accounted for US$ 0.05 billion in 2018 and is estimated to be 0.44 billion by 2026 and is anticipated to register a CAGR of 30.5%. The report. "Global 4D Printing in Healthcare Market, By Component (Equipment (3D Bioprinters and 3D Printers), Programmable Materials (Living Cells, Hydrogels, and Shape-Memory Materials), and Software & Services), By Technology (Fusion Deposition Modeling (FDM), PolyJet, Stereolithography, and Selective Laser Sintering (SLS)), By Application (Medical Models, Surgical Guides, and Patient-Specific Implants), By End-User (Hospitals & Clinics, Dental Laboratories, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”. Key Highlights: On In May 2018, Organovo Holdings, Inc. & Samsara Sciences, Inc. signed a partnership with advanced regenerative manufacturing institute (‘ARMI’) (US) to lainch next-generation manufacturing technologies and processes for cells, tissues, and organs. In May 2018, 3D Systems introduced Simbionix ANGIO Tab Pro endovascular simulator. The ANGIO Tab Pro is a first-to-market solution manufactured for step-by-step training of endovascular interventions. It includes 30 modules from basic skills to advanced and complex endovascular procedures, and more than 250 patient scenarios. The lightweight construction renders the ANGIO Tab Pro is an ultra-portable solution, making it ideal for use at conferences, as well as in the physician's clinic or home. Analyst View: Growing levels of advancements and innovations in technology for 3D printing services Growing need of organ transplants, wide range of application, and benefits associated with 4D technology are the key factors of the global 4D printing market in healthcare. For instance, the technology can produce implant as per intended and which can grow with patient’s growth. Additionally, the technology also reduces the need of surgical procedure by introducing self-deforming component to treat any abnormality in the body. 4D printing technology is also beneficial in research studies as the technology can design product at the time of development and design stage. Increasing strategic partnerships Research publications based on this technology are rising owing to availability of funding and growing focus of scientist of this new technology. Further, key players are involved in product launches and expansion of their market protocol in order to strengthen the market growth. In January 2017, 3D Systems’ acquired with Vertex-Global Holding B.V. to improve 3D Systems dental product offerings with the NextDent and Vertex brands. This also helped the company to establish a position in the dental industry by increasing the adoption of 3D-printed products for advanced solutions. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global 4D Printing in Healthcare Market”, By Component (Equipment (3D Bioprinters and 3D Printers), Programmable Materials (Living Cells, Hydrogels, and Shape-Memory Materials), and Software & Services), By Technology (Fusion Deposition Modeling (FDM), PolyJet, Stereolithography, and Selective Laser Sintering (SLS)), By Application (Medical Models, Surgical Guides, and Patient-Specific Implants), By End-User (Hospitals & Clinics, Dental Laboratories, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030 Key Market Insights from the report: The global 4D printing in healthcare market accounted for US$ 0.05 billion in 2018 and is estimated to be 0.44 billion by 2026 and is anticipated to register a CAGR of 30.5%. The market report has been segmented on the basis of component, technology, application, end-user, and region. By component, the software & services segment is projected to lead the market in 2021 and witness highest growth over the forecast period. Software has a varied range of benefits in additive manufacturing. 3D printing software is utilized for designing, creating, and assembling models needed in the healthcare space. By technology, the PolyJet segment is projected to register the largest growth in the coming years. This technology helps to development complex shapes with intricate delicate and details features. It offers products with a variety of materials and colors into a single model. By application, the medical & research models segment is projected to register for the highest share of the market. These models can be adapted as per the patient’s pathology, which will further provide efficient patient care. The presence of the 4D printing technology to produce smart medical models will bring lucrative transformation in the medical field and will drive the growth of this segment over the forecast period. By end-user, the target market is segmented into hospitals & clinics, dental laboratories, and others. By region, North America is projected to be the highest regional market for 4D printing in healthcare. This can majorly be attributed to the growing demand for organ transplantation, continuous technological advancements, presence of highly developed healthcare infrastructure, and the efforts taken in the research & development of the 4D printing technology in the healthcare sector in the region To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-4D-Printing-in-Healthcare-Market-4263 Competitive Landscape: The prominent player operating in the global 4D printing in healthcare market includes 3D Systems, Inc., Organovo Holdings Inc., Dassault Systèmes, Stratasys Ltd., Materialise, EOS, EnvisionTEC, Poietis - 4D Bioprinting, Allevi, Tractus3D, and 3D HUBS B.V. The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces Analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights Email- sales@prophecymarketinsights.com

The report "Global Migraine Drugs Market, By Treatment (Abortive Or Acute (Triptans, Ergot Alkaloids, and Anti-Nausea Medications) and Prophylactic Or Preventive (Botulinum Toxin, Topiramate, And Glucocorticoids)), By Route of Administration (Oral, Injectable, and Others (Nasal Spray and Transdermal Patch), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and Region - Global Forecast to 2029" Global migraine drugs market is projected to grow from US$ 2.2 billion in 2020 to US$ 8.3 billion by 2029. Increasing incidences of migraine attack will increase demand for antimigraine drugs across the globe is major factor driving the global migraine drugs market. Furthermore, rising R&D activities for drug development, coupled with growing manufactures launches antimigraine drug boosts the global migraine drug market. Key Highlights: In September 2018, Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) have approved Emgality (galcanezumab-gnlm) 120 mg injection for the preventive treatment of migraine in adults. On August 2018, Novartis Pharmaceuticals Canada Inc announced that Health Canada has approved Aimovig (erenumab) for the prevention of migraine in adults who have at least four migraine days per month. Key Market Insights from the report: The global migraine drugs market accounted for US$ 2.2 billion in 2020 and is projected to register a moderate CAGR of 15.7 % over the forecast period. The market report has been segmented on the basis of treatment, route of administration, distribution channel, and region. By treatment, the global migraine drugs market is segmented into abortive or acute and prophylactic or preventive. Abortive or acute sub-segment is categorized into triptans, ergot alkaloids, and anti-nausea medications. Further, prophylactic or preventive sub-segment is bifurcated into botulinum toxin, topiramate, and glucocorticoids. By route of administration, the global migraine drugs market is classified into oral, injectable, and others. Others route of administration sub-segment is nasal spray and transdermal patch. By distribution channel, the global migraine drugs market is categorized into retail pharmacies, hospital pharmacies, and online pharmacies. By region, North America migraine drugs market is expected to account for major revenue share in global migraine drugs market, followed by other regions. This is attributed to rising penetration of migraine in the countries of the North America region. The Asia Pacific migraine drugs market is emerging market in the global migraine drugs market in 2018. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on "Global Migraine Drugs Market”, By Treatment (Abortive Or Acute (Triptans, Ergot Alkaloids, and Anti-Nausea Medications) and Prophylactic Or Preventive (Botulinum Toxin, Topiramate, And Glucocorticoids)), By Route of Administration (Oral, Injectable, and Others (Nasal Spray and Transdermal Patch), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)- forecast till 2029 To know the upcoming trends and insights prevalent in this market, click the link below: Links https://www.prophecymarketinsights.com/market_insight/Global-Migraine-Drugs-Market-By-833 The prominent player operating in the global migraine drugs market includes Pfizer Inc, GlaxoSmithKline plc, Allergan plc, Amgen Inc, Eli Lilly and Company, Teva Pharmaceuticals USA, Inc, Biohaven Pharmaceutical Holding Company Ltd, Johnson & Johnson, Novartis Pharmaceuticals Canada Inc., and Alembic Pharmaceuticals Limited. About Prophecy Market Insights Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. Contact Us: Sales Prophecy Market Insights Email- sales@prophecymarketinsights.com

The Global Medical Bed Market accounted for US$ 3.05 billion in 2020 and is estimated to be US$ 5.49 billion by 2030 and is anticipated to register a CAGR of 6.1%. Hospital beds are designed for patients that offer hygiene and cleanliness as it is not properly maintained by household beds. Hospital beds have an adjustable height and provide various benefits as it delivers ease and comfort to patient while getting treatment. Hospital beds can be custom made for various patients based on the treatment. Along with patients, hospitals bed can provide convenience to care taker as they can maintain cleanliness and hygiene properly. Number of hospital beds is used to measure the capacity and amount of space of hospital facilities. The report “Global Medical Bed Market, By Usage (Acute Care, Long Term Care, Psychiatric Care, and Maternity), By Application (Intensive Care and Non Intensive Stage), By Power (Electric Beds, Semi Electric Bed, and Manual Bed), By End-User (Hospital, Home care settings, and Elderly care facilities), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: In 2021, Hyderabad techies launch AI tool to forecast number of hospital beds needed to tackle Covid. IN 2021, Mastercard and American India Foundation (AIF) launch first portable hospital in Jalna district Maharashtra. Analyst View: Increasing prevalence of elderly population suffering from acute and chronic disease such as COPD, alzheimer’s, and diabetes is driving the growth of global medical bed market. For an instance, according to Diabetes UK organization, in the UK, around 15% of overall hospital beds has been occupied by the diabetic people. In addition, rising collaboration between private organization and government for infrastructure development is anticipated to further drive growth of the target market over the forecast period. Furthermore, market players are developing advance technology in hospital beds to provide safety and comfort to patients which in turn is expected to boost the growth of medical bed market. Moreover, increasing healthcare spending and demand for better healthcare facilities is expected to drive the sales of hospital beds globally. Additionally, growing demand for beds in private hospitals, increasing medical tourism, etc. are also some crucial factors propelling the growth of the global medical bed market. However, high cost incurred during manufacturing of hospital beds is a major factor restraining growth of the global medical bed market. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Medical Bed Market, By Usage (Acute Care, Long Term Care, Psychiatric Care, and Maternity), By Application (Intensive Care and Non Intensive Stage), By Power (Electric Beds, Semi Electric Bed, and Manual Bed), By End-User (Hospital, Home care settings, and Elderly care facilities), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Medical-Bed-Market-By-1087 Key Market Insights from the report: The Global Medical Bed Market accounted for US$ 3.05 billion in 2020 and is estimated to be US$ 5.49 billion by 2030 and is anticipated to register a CAGR of 6.1%. The global medical bed market is segmented into usage, application, power, end-user and region. By Usage, the Global Medical Bed Market is segmented into acute care, long term care, psychiatric care, and maternity. By Application, the Global Medical Bed Market is segmented into intensive care and non-intensive stage. By Power, the Global Medical Bed Market is segmented into electric beds, semi electric bed, and manual bed. By End-User, the Global Medical Bed Market is segmented into hospital, home care settings, and elderly care facilities. By region, the Global Medical Bed Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has the largest market in terms of revenue due to high healthcare spending in the region as well as increasing chronic disease patient base in the region. Competitive Landscape: Some of the prominent players operating in the global medical bed market include Stryker Corporation, Hill-Rom Holding, Inc., Getinge Group, Invacare Corporation, Medline Industries, Inc., Stiegelmeyer GmbH & Co. Kg, Antano Group S.R.L, Amico Corporation, Midmark Corporation, and Linet Spol. S.R.O. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.com

The Global Eubiotics Market accounted for US$ 4.8 billion in 2020 and is estimated to be US$ 9.8 billion by 2030 and is anticipated to register a CAGR of 7.5%. Eubiotics term refers to the upkeep of micro flora within the intestinal tract. Eubiotics are mainly wont to improve the health status also as performance improvement in domesticated animals. They mostly include probiotics, prebiotics, organic acids and essential oils. The efficacy of the merchandise is especially hooked in to the antimicrobial effects also as their ability to change the gut flora. Eubiotics are gaining importance in developed countries with an increasing number of nations are limiting the utilization of antibiotics. Eubiotics helps in improving the system and thus plays a significant role within the system. Eubiotics are the natural digestive stimulants, which create healthy balance of micro flora within the alimentary canal. For the activation of the immune reaction against diseases the inclusion of dietary organic acids features a eubiotic effect on the proliferation of indigenous carboxylic acid bacteria. It refers to feed additives like prebiotics, probiotics, and organic acids. Eubiotics are good for digestive health and act as a substitute to antibiotics in feed. The report " Global Eubiotics Market, By Product (Probiotics, Prebiotics, Organic Acids, and Essential Oils), By Dosage Form (Dry and Liquid), By Application (Gut Health, Immunity, Yield, and Others (Productivity and Nutrition)), By Livestock (Poultry, Swine, Aquatic, and Ruminants), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast Till 2030” Key Highlights: In 2021, DSM has acquired Midori USA, Inc, a biotechnology start-up with a novel precision platform developing breakthrough targeted eubiotics that improve the health and environmental impact of animals. In 2020, Biomin has launched a new mycotoxin and endotoxin deactivation product designed specifically for the fattening period in poultry and swine. Analyst View: Increasing awareness regarding meat quality, coupled with the rising demand for animal protein products across the globe are major factors driving growth of the global eubiotics market. In addition, ban on use of antibiotics in some countries boost the demand for its alternatives such as eubiotic which is another factor propelling growth of the target market. Furthermore, adverse health effect on animals due to use of antibiotics is supporting growth of the target market. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Eubiotics Market, By Product (Probiotics, Prebiotics, Organic Acids, and Essential Oils), By Dosage Form (Dry and Liquid), By Application (Gut Health, Immunity, Yield, and Others (Productivity and Nutrition)), By Livestock (Poultry, Swine, Aquatic, and Ruminants), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast Till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Eubiotics-Market-By-Product-551 Key Market Insights from the report: The Global Eubiotics Market accounted for US$ 4.8 billion in 2020 and is estimated to be US$ 9.8 billion by 2030 and is anticipated to register a CAGR of 7.5%. The global eubiotics market has been segmented on the basis of product, dosage form, application, livestock, and region. By Product Type, the market is segmented into probiotics, prebiotics, organic acids, and essential oils. By Dosage Form, the market is segmented into dry and liquid. By Application, the market is segmented into gut health, immunity, yield, and others. Others sub-segment includes productivity and nutrition. By Livestock, the market is segmented into poultry, swine, aquatic, and ruminants. By Region, the Global Diabetic Neuropathy Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Competitive Landscape: Key players operating in the global eubiotics market includes Cargill INC, BASF SE, E. I. du Pont de Nemours and Company, Koninklijke DSM N. V., Chr. Hansen Holding A/S, Novozymes A/S, Calpis Co., Ltd., Lesaffre et Compagnie, SA, Kemin Industries, Inc., and Lallemand Inc. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning. Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period. Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.co

The Global Smart Contact Lenses Market accounted for US$ 159.09 million in 2020 and is estimated to be US$ 916.17 million by 2030 and is anticipated to register a CAGR of 10.40%. Aesthetics and cosmetics are the most motivating factors for people that want to avoid wearing glasses or to vary the looks or color of their eyes. Others wear contact lenses for functional or optical reasons. In comparison with spectacles, contact lenses typically provide better sight, and don't collect moisture (from rain, snow, condensation, etc.) or perspiration. This will make them preferable for sports and other outdoor activities. Contact wearers also can wear sunglasses, goggles, or other eyewear of their choice without having to suit them with prescription lenses or worry about compatibility with glasses. Additionally, there are conditions like keratoconus and aniseikonia that are typically corrected better with contact lenses than with glasses. The report “Global Smart Contact Lenses Market, By Type (Daily-Wear Soft Lenses, Extended- Wear Lenses, Rigid Gas- Permeable (RGP) Lenses, and Extended- Wear Disposable Lenses), By Product Type (Disposable Type and Frequent Replacement Type), By Application (Intraocular Pressure Monitoring and Continuous Glucose Monitoring), By End-User Type (Clinics, Home Care Settings, and Hospitals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: In August 2019, Samsung Electronics Co. Ltd. patented smart contact lenses that lets having controlling over phone by blinking. On 26th of July 2021, INMO announced its latest innovation on the crowd funding platform Indiegogo. INMO Air is a pair of wireless lightweight AR smart glasses that delivers a completely hands-free connection between technology and real life. Analyst View: Smart Contact Lenses can control the myopia which is the propelling factor for the growth of global market. Furthermore, during the physical and sports activities the lenses are better for vision instead of eyeglasses which is expected to drive the target market growth over the forecast period. Smart contact lenses improve the vision by eliminating the spectacles which is the another fueling factor for the growth of target market. In addition, the smart contact lenses are worn for the aesthetic use which is the major boosting factor for the growth of global market. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Smart Contact Lenses Market, By Type (Daily-Wear Soft Lenses, Extended- Wear Lenses, Rigid Gas- Permeable (RGP) Lenses, and Extended- Wear Disposable Lenses), By Product Type (Disposable Type and Frequent Replacement Type), By Application (Intraocular Pressure Monitoring and Continuous Glucose Monitoring), By End-User Type (Clinics, Home Care Settings, and Hospitals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/global-smart-contact-lenses-market-3567 Key Market Insights from the report: The Global Smart Contact Lenses Market accounted for US$ 159.09 million in 2020 and is estimated to be US$ 916.17 million by 2030 and is anticipated to register a CAGR of 10.40%. The global smart contact lenses market report segments the market on the basis of type, product type, application, end-user type, and region. Based on type, the Global Smart Contact Lenses Market is segmented into the Daily-Wear Soft Lenses, Extended- Wear Lenses, Rigid Gas- Permeable (RGP) Lenses, and Extended- Wear Disposable Lenses. Based on product type, the Global Smart Contact Lenses Market is segmented into the Disposable Type and Frequent Replacement Type. Based on application, the Global Smart Contact Lenses Market is segmented into Intraocular Pressure Monitoring and Continuous Glucose Monitoring. Based on end-user, the Global Smart Contact Lenses Market is segmented into Clinics, Home Care Settings, and Hospitals. By region, the Global Smart Contact Lenses Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global smart contact lenses market owing to rising demand for smart contact lenses. Competitive Landscape: The key players in Global Smart Contact Lenses Market are Sensimed AG, Google Inc., Alcon laboratories Inc., Samsung Electronics Co. Ltd., Innovega Inc., Novartis AG, Bausch & Lomb Inc., Sony Electronics Inc, Sensimed SA and Johnson & Johnson Surgical Vision Inc. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.co

The global medical cameras and microscopes market accounted for US$ 2.3 billion in 2019 and is estimated to be US$ 5.2 billion by 2029 and is anticipated to register a CAGR of 8.3%. Increasing prevalence of the chronic diseases such as cancer and blood disorder is mainly to offer lucrative avenue for the growth of the medical cameras and microscopes market in the coming years. The report "Global Medical Cameras and Microscopes Market, By Cameras Type (Endoscopy Cameras, Dermatology Cameras, Ophthalmology Cameras, Dental Cameras, Surgical Microscope Cameras (Ophthalmology, ENT, and Neurosurgery), and Pathology Microscope Cameras (Hospital Laboratories, Diagnostic Laboratories, and Physician Offices)) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029”. Impact of Covid-19 pandemic on market Due to the outbreak of Covid-19 pandemic globally, imaging modalities is widely preferred by most healthcare professionals as it provides a primary diagnosis in a short time. All the imaging technologies involving nuclear imaging have been used exhaustively to study Covid-19 and its effect on different patients in each demography. The increasing requirement for advanced imaging solutions is projected to drive the development studies globally. The report will account for Covid19 as a key market contributor. Key Highlights: On June 2020, Olympus, a leader in delivering optical and software solutions for the life sciences, and PhenoVista, a leading provider of custom imaging-based phenotypic assay services, are collaborating to deliver 3D cell-based assay services for drug discovery. On April 2020, Olympus Corporation declared the launch of EVIS X1, its most advanced endoscopy system to date. The new system is to improve outcomes from disorders of the colon, stomach, and oesophagus, as well as from bronchial diseases, by providing every endoscopist with innovative and proven tools. The launch of EVIS X1 further strengthens Olympus’ leadership in endoscopy and continued medical focus. Analyst View: Growing inclination of patients towards invasive surgeries is a robust factor likely to drive the global medical cameras and microscopes market in the coming years. Additionally, growth in the use of medical camera and microscopes for surgeries such as ophthalmology, neurosurgeries is another factor expected to boost the global medical cameras and microscopes market. Furthermore, advancement in medical devices is growing the demand of the medical cameras and microscopes in the market. For instance, Olympus Corporation introduced ORBEYE Surgical Microscope. The device is based on 4K 3D video technology. Sony Imaging Products & Solutions Inc. and Olympus Corporation have developed this technology. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Medical Cameras and Microscopes Market”, By Cameras Type (Endoscopy Cameras, Dermatology Cameras, Ophthalmology Cameras, Dental Cameras, Surgical Microscope Cameras (Ophthalmology, ENT, and Neurosurgery), and Pathology Microscope Cameras (Hospital Laboratories, Diagnostic Laboratories, and Physician Offices)) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029 Key Market Insights from the report: The global medical cameras and microscopes market accounted for US$ 2.3 billion in 2019 and is estimated to be US$ 5.2 billion by 2029 and is anticipated to register a CAGR of 8.3%. The market report has been segmented on the basis of cameras type and region. By cameras type, endoscopy is the highest segment, due to the use of life science imaging technique for conducting surveillance in tight spaces such as cavity of the body or hollow organ. Further, the pathology microscopes segment includes hospital laboratories, diagnostic laboratories, and physician offices. The hospital is the highest segment of pathology microscopes due to the greater financing capabilities and higher number of patient admissions and surgeries performed in hospitals. By region, North America is expected to account for major market share in terms of revenue in the target market as compared to that of other regions. This can be attributed due to rising proportion of geriatric population and the increasing prevalence of diseases such as cancer in the countries of the region. To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Medical-Cameras-and-Microscopes-447 Competitive Landscape: The prominent player operating in the global medical cameras and microscopes market includes Olympus Corp., Carl Zeiss Meditec AG., Nikon Corp., Leica Microsystems AB., Danaher Corp., Allied Vision GmbH., Topcon Corp., SPOT Imaging Solutions Ltd., Stryker Corp., and JOEL Ltd. The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: COVID-19 impact on the market, detailed analysis on economic, health and financial structure. Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces Analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights Email- sales@prophecymarketinsights.com

Global Plant Stem Cell Market accounted for US$ 10.57 billion in 2020 and is estimated to be US$ 24.88 billion by 2030 and is anticipated to register a CAGR of 8.9%. Plant stem cells are undifferentiated cells, it can serve as the origin of plant life for maintain themselves and provide a steady supply of precursor cells for forming various tissues and organs in plants. Plant stem cells are located in the meristems of plants, and plant stem cell therapy is also called gemmotherapy. It has two distinguishing characteristics: the ability to differentiate cell types and the ability to self-renew so that number of stem cells remains steady. Plant cell extracts can be obtained through complex cultivation and extraction processes. Essentially plant sources are alpine rose, grape, edelweiss, Swiss apple, gardenia, etc. From those, the Swiss apple and grape are most widely used in the industry. Plant stem cell technology is also used in the cosmetics industry for the manufacture of skin and hair, among others. The report " Global Plant Stem Cell Market, By Location (Shoot Apical Meristems, Root Apical Meristems, and Vascular Meristems), By Application (Pharmaceutical, Nutrition, and Cosmetics) and By Region (North America, Europe, Latin America, Middle East, Asia Pacific, and Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: In 2021, CellaBeauty LLC Launched Plant Based Stem Cell Skincare. CellaBeauty LLC is a skincare company at the lead of ethical and inexpensive stem cell solutions for aging skin. Plant-Based Stem Cell Skincare line with the help of swiss “Ageless Apple”, mostly using apple plant stem cells are extracted, and they found only in a remote town. Analyst View: The plant stem cell growth is constantly spurted by various researches on various plants to explore their inherent application in the market. Naturally occurring botanicals contain antioxidant levels which can protect human skin cells from UV. The major driver for the plant stem cell market is the growing demand for natural compounds in the populace. Plant stem cell cultures have positive results in the cosmetics industry, it is widely used in the cosmetic industry, have offered a large range of opportunities for the skincare and hair treatments which are contaminant free and use the bio-sustainable product. Furthermore, increasing demand for anti-aging, skincare, hair care, and other cosmetics products rise the growth of the plant stem cell market. Furthermore, an increase in air and water pollution, medical spas, and medical tourism boost the growth of skin care products. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Plant Stem Cell Market, By Location (Shoot Apical Meristems, Root Apical Meristems, and Vascular Meristems), By Application (Pharmaceutical, Nutrition, and Cosmetics) and By Region (North America, Europe, Latin America, Middle East, Asia Pacific, and Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Plant-Stem-Cell-Market-65 Key Market Insights from the report: Global Plant Stem Cell Market accounted for US$ 10.57 billion in 2020 and is estimated to be US$ 24.88 billion by 2030 and is anticipated to register a CAGR of 8.9%. The Global Plant Stem Cell Market is segmented by Location, Application, and Region. By Location, the Global Plant Stem Cell Market is segmented into Shoot Apical Meristems, Root Apical Meristems, and Vascular Meristems. By Application, Global Plant Stem Cell Market is segmented into Pharmaceutical, Nutrition, and Cosmetics. By region, the Global Plant Stem Cell Market is segmented into North America, Europe, Latin America, Middle East, Asia Pacific, and Africa. Competitive Landscape: The key players operating in the global market of plant stem cells include Aidan Products LLC, Oriflame Holding AG, Phyto Science SDN BHD, Natura Therapeutics Inc, MyChelleDermaceuticals, LLC, Mibelle Biochemistry, and Renature Skin Care Inc. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.co

Global Human Microbiome Market accounted for US$ 590.39 million in 2020 and is estimated to be US$ 3657.31 million by 2030 and is anticipated to register a CAGR of 19.8%. Human tissue is covered with trillions of microorganisms, these microorganisms include bacteria, fungi, and viruses which are known as the microbiome. They contribute 2-3Kg weight inside the human body in the abundance of human microbes. Technological advancement and analytical techniques increase the microbiome. Human microbiome is an aggregate of all microbiota that resides within human tissues and biofluids with corresponding anatomical sites, including the mammary glands, skin, uterus, seminal fluid, lung, saliva, ovarian follicles, conjunctiva, oral mucosa, and gastrointestinal tract. The report " Global Human Microbiome Market, By Product (Obesity, Diabetes, Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, and Other Diseases), By Disease (Probiotics, Prebiotics, Synbiotic, and Other Products), By Application (Therapeutic and Diagnostic), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: On 23 September 2021, PhenoBiome launched the first human gut microbiome assay through Genetic Direction, which is Dallas-based distributor of genetics-based health management programs, and also Clinical Enterprise, Inc., a Eurofins Scientific company, will process the assays in its CLIA- and CAP-certified laboratory. On 12 October 2021, Consumer Dermatology Company announces, DERMALA, Additions to a Successful Acne Product Range pretended for treatment of acne powered by the human microbiome extends its products, and also line up with the addition of six new products. The line extension combines SUPPLEMENT to Be Daily Pre Probiotic Skin Mix, Best CLEANSE Forever Hydrating Cleanser for Sensitive/Normal Skin, SUPPLEMENT to Be Daily Vitamin Skin Mix. 4D pharma merged with Longevity Acquisition Corporation to earn a NASDAQ listing in 2020. In accomplishment, Longevity will support and accelerate the ongoing development of 4D pharma’s Live Biotherapeutic, it is a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, which helps to cure disease In 2020, BiomX collaborated with Boehringer Ingelheim to utilize the microbiome-based biomarker discovery platform to probably identify biomarkers associated with patient phenotypes in Inflammatory Bowel Disease (IBD). Analyst View: Rising focus on human micro biome therapeutics development -Human gut microbiomes play a role in improving the efficacy of therapeutic compounds, study shows the right combination of microbes in the human body is beneficial for treating different conditions, the association among microbes and specific disease states can generate opportunities for drug developers or vaccine manufacturers. Many small innovative players are operating in the market there are various high-growth opportunities for stakeholders to buy out companies to study microbiomes in the hopes to identify new drugs and drug targets for indication, like liver disorders, obesity, diabetes, and metabolic disorders. The human body is a diverse community of symbolic, pathogenic microorganisms, and commensal, collectively known as microbiota. In that only 30-40 species as the bulk of microbiota is shared among individuals, analyzing specific bacteria from trillions of species is a highly challenging task. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Human Microbiome Market, By Product (Obesity, Diabetes, Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, and Other Diseases), By Disease (Probiotics, Prebiotics, Synbiotic, and Other Products), By Application (Therapeutic and Diagnostic), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Human-Microbiome-Market-By-3787 Key Market Insights from the report: Global Human Microbiome Market accounted for US$ 590.39 million in 2020 and is estimated to be US$ 3657.31 million by 2030 and is anticipated to register a CAGR of 19.8%. The Global Human Microbiome Market is segmented by Product, Disease, Application, and Region. By Product, Global Human Microbiome Market is segmented into Obesity, Diabetes, Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, and Other Diseases. By Disease, Global Human Microbiome Market is segmented into Probiotics, Prebiotics, Synbiotic, and Other Products. By Application, Global Human Microbiome Market is segmented into Therapeutic and Diagnostic. By Region, Global Human Microbiome Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Competitive Landscape: The key players operating the global human microbiome market involves Enterome Bioscience, Yakult, Dow DuPont Inc., Seres Therapeutics, ViThera Pharmaceuticals, Second Genome Inc., MatriSys Bioscience, Caelus Health, Rebiotix Inc., Assembly Biosciences Inc. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below: Explains an overview of the product portfolio, including product development, planning, and positioning Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies. Detailed analysis of the market revenue over the forecasted period. Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis. Study on the segments that are anticipated to dominate the market. Study on the regional analysis that is expected to register the highest growth over the forecast period Key Topics Covered Introduction Study Deliverables Study Assumptions Scope of the Study Research Methodology Executive Summary Opportunity Map Analysis Market at Glance Market Share (%) and BPS Analysis, by Region Competitive Landscape Heat Map Analysis Market Presence and Specificity Analysis Investment Analysis Competitive Analysis To know more Contact Us: Sales Prophecy Market Insights 1 860 531 2701 Email- sales@prophecymarketinsights.co